KLOW (BPC+TB+GHK+KPV)

KLOW is a precision-engineered peptide formulation designed to target multiple pathways of regeneration, recovery, and systemic support. Each serving delivers GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), and KPV (10 mg), providing a broad-spectrum research profile.

• GHK-Cu is a naturally occurring copper-binding peptide studied for its role in collagen synthesis, wound healing, skin rejuvenation, and cellular repair.

• BPC-157 is a stable gastric pentadecapeptide investigated for accelerating tendon, ligament, and muscle healing while supporting gastrointestinal and vascular protection.

• TB-500, a synthetic fragment of Thymosin Beta-4, is studied for its ability to promote angiogenesis, cell migration, and tissue regeneration.

• KPV, a tripeptide fragment of α-MSH, is investigated for its potent anti-inflammatory and antimicrobial properties, supporting immune modulation and tissue recovery.

Together, these peptides create a synergistic profile aimed at enhancing repair, reducing inflammation, and supporting regenerative research across musculoskeletal, vascular, and dermatological systems.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.